BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30195644)

  • 1. Venom as therapeutic weapon to combat dreadful diseases of 21
    Khusro A; Aarti C; Barbabosa-Pliego A; Rivas-Cáceres RR; Cipriano-Salazar M
    Microb Pathog; 2018 Dec; 125():96-107. PubMed ID: 30195644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal Venoms have Potential to Treat Cancer.
    Chatterjee B
    Curr Top Med Chem; 2018; 18(30):2555-2566. PubMed ID: 30574852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tubercular peptides: A quest of future therapeutic weapon to combat tuberculosis.
    Khusro A; Aarti C; Agastian P
    Asian Pac J Trop Med; 2016 Nov; 9(11):1023-1034. PubMed ID: 27890360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insects, arachnids and centipedes venom: A powerful weapon against bacteria. A literature review.
    Fratini F; Cilia G; Turchi B; Felicioli A
    Toxicon; 2017 May; 130():91-103. PubMed ID: 28242227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer potential of animal venoms and toxins.
    Gomes A; Bhattacharjee P; Mishra R; Biswas AK; Dasgupta SC; Giri B
    Indian J Exp Biol; 2010 Feb; 48(2):93-103. PubMed ID: 20455317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond.
    Ageitos L; Torres MDT; de la Fuente-Nunez C
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Venom Proteins as Potential Anticancer Agents.
    Ejaz S; Hashmi FB; Malik WN; Ashraf M; Nasim FU; Iqbal M
    Protein Pept Lett; 2018; 25(7):688-701. PubMed ID: 29921199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthropod venoms and cancer.
    Heinen TE; da Veiga AB
    Toxicon; 2011 Mar; 57(4):497-511. PubMed ID: 21236287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helminthes and insects: maladies or therapies.
    El-Tantawy NL
    Parasitol Res; 2015 Feb; 114(2):359-77. PubMed ID: 25547076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal Venom Peptides: Potential for New Antimicrobial Agents.
    Primon-Barros M; José Macedo A
    Curr Top Med Chem; 2017; 17(10):1119-1156. PubMed ID: 27697042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centipede venoms and their components: resources for potential therapeutic applications.
    Hakim MA; Yang S; Lai R
    Toxins (Basel); 2015 Nov; 7(11):4832-51. PubMed ID: 26593947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory properties of molecules from animal venoms.
    Minutti-Zanella C; Gil-Leyva EJ; Vergara I
    Toxicon; 2021 Feb; 191():54-68. PubMed ID: 33417946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer potential of bioactive peptides from animal sources (Review).
    Wang L; Dong C; Li X; Han W; Su X
    Oncol Rep; 2017 Aug; 38(2):637-651. PubMed ID: 28677775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ants: a chemical library of anticancer molecules].
    Vétillard A; Bouzid W
    Biol Aujourdhui; 2016; 210(2):119-25. PubMed ID: 27687602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of animal venoms.
    Russell FE
    Clin Pharmacol Ther; 1967; 8(6):849-73. PubMed ID: 4383460
    [No Abstract]   [Full Text] [Related]  

  • 17. Animal Venoms as Potential Source of Anticonvulsants.
    Zainal Abidin SA; Liew AKY; Othman I; Shaikh F
    F1000Res; 2024; 13():225. PubMed ID: 38919947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options.
    Chatterjee M; Anju CP; Biswas L; Anil Kumar V; Gopi Mohan C; Biswas R
    Int J Med Microbiol; 2016 Jan; 306(1):48-58. PubMed ID: 26687205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaching the golden age of natural product pharmaceuticals from venom libraries: an overview of toxins and toxin-derivatives currently involved in therapeutic or diagnostic applications.
    Fox JW; Serrano SM
    Curr Pharm Des; 2007; 13(28):2927-34. PubMed ID: 17979737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.